The most revealing sentence on Wasson Enterprise's website may be the least glamorous: the firm says its people get involved for a “finite time frame.” In an industry fluent in permanent-sounding promises, that bit of calendar discipline is refreshing. WE, as the Chicago family office calls itself, does not claim to become a founder's new shadow government. It supplies money, experience and a phone book, then concentrates its effort where a growing company is most likely to wobble.
That could mean finding an executive, shaping a funding plan, rebuilding a marketing function or working through an operational knot. The menu on its “build” page is blunt: marketing, human resources, finance, funding, operations and software enhancement. Those are not products in the software sense. They are the unphotogenic jobs between a promising idea and a repeatable business.
A family office with operator muscle
WE began in 2016 with Greg and Kim Wasson, their daughter Lindsay Wasson Lingle and son-in-law Mike Lingle. Greg brought the longest operating résumé. He entered Walgreens as a pharmacy intern, spent 35 years at the company and eventually served as chief executive as it became Walgreens Boots Alliance. The useful inheritance was not simply wealth. It was pattern recognition from healthcare, retail, logistics, people management and very large systems.
The founders aimed that experience at three early lanes: health technology, consumer and retail, and clean technology. Over time, the portfolio widened. WE's public roster now moves from dental studios and health-navigation companies to data-center efficiency, advanced packaging, real estate funds and lunar infrastructure. The apparent sprawl makes more sense when seen through a second filter: where can this specific group improve the odds?
WE invests directly and through funds, and across venture, growth and real estate. That range would be awkward inside a conventional closed-end venture fund, whose mandate dictates stage, ownership and timetable. A single-family office can be more elastic. It can join at different points, return in a later financing and decide that a useful relationship matters more than fitting a company into a standard box.
“When we partner, we mean business.”Wasson Enterprise
The product is practical leverage
Founders are the obvious customers, but not the only ones. WE also backs funds, works with executives in established companies and participates in private-equity situations. The common customer has a growth opportunity and a shortage of something other than ambition: experienced hands, a senior hire, a commercial introduction, a financing connection or operating bandwidth.
In 2018, the firm created WE People Solutions, an internal professional employer organization, after seeing partners without adequate human-resources infrastructure. That detail says more about the model than a page of investment jargon. Instead of diagnosing “talent” as an abstract risk, the firm built a mechanism to handle it. WE still keeps its own headcount tight, adding people only for critical needs and using outside specialists for the rest.
The business model is straightforward at the top and private underneath. WE deploys family capital and earns returns from ownership and investment outcomes. It does not publish assets under management, revenue, check sizes or a standard fee schedule. The absence of a fundraising treadmill can be an advantage: patient capital need not manufacture an exit merely because a fund clock says so. It can also be a limitation. A small team has to ration its attention, and its site is candid that not every inbound idea receives a response.
A portfolio built around hard transitions
The firm's most legible work sits where technology meets stubborn physical systems. In 2017, WE partnered with commercialization specialist Innventure and supported PureCycle Technologies, which licensed a Procter & Gamble process designed to remove color, odor and contaminants from polypropylene waste. Laboratory promise was only the start. Plants, feedstock, manufacturing economics and customer qualification all had to follow.
The same year, WE co-founded Cooler Screens, now CoolerX, turning refrigerated store doors into digital merchandising surfaces. In 2019, it led a consortium that secured majority ownership of iA, a pharmacy-automation company. Each case asks a similar question in a different costume: can software, machinery and operating design remove friction from a familiar industry?
Healthcare remains the clearest home field. Pharmacy is woven into the family's story, and the portfolio includes health-navigation, diagnostics, care delivery and benefits businesses. In 2025, WE and Ascendant Advisory Group bought Healthcare Horizons, a claims-auditing and recovery company serving self-insured employers and payers. WE's own timeline describes a 40 percent stake. The work is unfashionable but concrete: test whether claims were paid accurately, recover overpayments and improve oversight.
Later that year, WE announced a collaboration with MOBE, whose model combines analytics, personalized guidance and pharmacist support. The connection is easy to read. Greg Wasson's career was built around pharmacy as a point of care, not merely a place to collect a bottle. MOBE applies that idea to whole-person health and benefit costs. In March 2026, Greg joined the Healthcare Horizons board as that company appointed Roger Cheek chief executive.
The difference is timing, not theater
WE competes for opportunities with family offices, operator-led venture firms, growth investors and venture studios. Plenty promise networks and operating expertise. Its credible distinction is narrower: family capital across several vehicles, paired with executives who have run large retail and healthcare systems and a team willing to do bounded functional work.
That “bounded” part matters. Portfolio support easily becomes investor theater: a platform deck, a directory of advisers, a few energetic introductions. WE describes a more selective process. It asks where it can add value, assigns human capital at consequential stages and uses its broader network when a full-time internal hire would be wasteful. The approach is less like installing a permanent consulting department and more like bringing the right wrench to a noisy machine.
Capital buys time. An operator's job is to make sure the company learns something before the time is gone.
There are trade-offs. Sector breadth can blur a thesis. “Investing in good” is a memorable mission, but not a measurable underwriting standard on its own. The sharper standard appears elsewhere in WE's language: positive impact, strong people, a credible idea and a situation where its network or team can alter the result. Good intentions may open the conversation; usefulness appears to close the deal.
Where WE sits in the capital stack
The market around WE has become crowded. Multistage venture firms have built recruiting and go-to-market teams. Private-equity sponsors keep full operating groups. Venture studios trade capital and labor for substantial ownership, while independent advisers sell the same functional expertise by the hour. A founder can assemble nearly every ingredient in WE's offer from separate providers.
The family office bundles those ingredients inside one long-duration relationship. It can invest through a fund before meeting a company directly, join a growth round later, or support a real asset that would sit outside a typical technology mandate. That flexibility is particularly useful around healthcare and industrial technology, where regulation, hardware and long customer cycles make neat venture timelines unreliable. A pharmacy automation system cannot be tested like a photo-sharing app. A recycling plant cannot pivot every Tuesday.
WE also occupies a middle ground between a financial sponsor and a venture builder. It does not publicly present a factory for launching dozens of companies, yet its history includes co-founding Cooler Screens and working alongside Innventure's commercialization engine. Nor does it describe a conventional buyout formula built on leverage and cost reduction. The recurring move is partnership: take an ownership position, identify a short list of value-creation jobs and recruit the right mix of employees, advisers and industry contacts.
For entrepreneurs, the fit depends on the bottleneck. A pure software founder chasing the fastest possible seed round may find a specialist fund with a larger follow-on reserve more natural. A healthcare, retail or industrial company facing channel access, executive hiring, manufacturing scale or complicated stakeholder economics is closer to WE's center of competence. The question is not whether the office has seen the exact product before. It is whether its operators have seen the system the product must enter.
A second-generation test
Family offices eventually face a question that venture firms can postpone: is the institution larger than its founder? In late 2025, Lindsay Wasson Lingle stepped into the chief executive role after serving as co-president. Her background gives the transition its own logic. Before WE, she worked in sales and marketing, earned an MBA and started the consumer accessories company Holly & Tanager. At the family office, she built marketing support for partner companies before moving into broader leadership.
That makes the handoff more than a surname change. It shifts the center of gravity from Greg's large-company operating memory toward Lindsay's experience building a younger consumer brand and working inside portfolio support. Mike Lingle, now chief strategy officer, adds experience across supply chain, operations, commercialization and capital strategy. Kim Wasson remains a co-founder and executive vice president.
WE marked its tenth anniversary in 2026 by telling its own origin story: a small group that did not begin with a polished family-office manual, then gradually formalized how it finds and helps partners. The useful lesson is not that every investor needs an HR service or a recycling company. It is that capital becomes more distinctive when an investor can name the work it is prepared to do, the moment it should arrive and the moment it should leave.
For a founder, that is the practical promise. WE can finance a company, but financing is not the final product. The product is a better route through the next hard transition: from lab to plant, store door to media network, prescription queue to automated fulfillment, or healthcare invoice to recovered dollar. The portfolio is varied. The bottleneck is the organizing principle.